The patent application date for Gleevec in China is April 2, 1993. Chinese law stipulates that the patent term expires in 20 years. Gleevec's patent period in China has expired on April 1, 2013. Gleevec cannot be produced legally. Gleevec is a specific cancer treatment drug developed by the Swiss company Novartis and is considered a medical miracle by many medical experts. As a patented drug, Gleevec's patent is strictly protected by law.
For more information on why China does not produce Gleevec, enter: /ask/5cc0321615836224.html?zd to view more content